# Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease

> **NCT00603590** · PHASE2 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 475 (actual)

## Conditions studied

- Cardiovascular Disease
- Hypertension
- Hyperlipidemia
- Heart Disease

## Interventions

- **DRUG:** Polypill
- **DRUG:** Placebo drug

## Key facts

- **NCT ID:** NCT00603590
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-06
- **Final completion:** 2008-07
- **Target enrollment:** 475 (ACTUAL)
- **Last updated:** 2009-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603590, "Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00603590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*